Genentech started clinical trials on the drug in October 1996. During clinical trials, six patients suddenly started coughing up blood, and four of them later died.
In October 1996, Genentech started testing a new drug. Unfortunately, during this trial phase, six patients unexpectedly began coughing up blood, leading to the untimely deaths of four others.